Results 31 to 40 of about 1,825 (197)

Assessment of lornoxicam as a mouth dissolving film in management of post extraction pain-A randomized control trial

open access: yesJournal of Indian Academy of Oral Medicine and Radiology, 2022
Background: Mouth dissolving film (MDF) is a fast-dissolving drug delivery system that provides a practical means to administer drugs not just to special populations with swallowing difficulties but also to the general public. MDFs are novel dosage forms
M Aparna Vijayan   +2 more
doaj   +1 more source

Preemptive analgesia by lornoxicam--an NSAID--significantly inhibits perioperative platelet aggregation

open access: yes, 2008
BACKGROUND AND OBJECTIVE: To investigate whether preemptive administered lornoxicam changes perioperative platelet function during thoracic surgery. METHODS: A total of 20 patients scheduled for elective thoracic surgery were randomly assigned to receive
Kimberger, O   +5 more
core   +1 more source

Intraarticular levobupivacaine lornoxicam and morphine analgesia after knee arthroscopy: a randomized controlled trial

open access: yesActa Orthopaedica et Traumatologica Turcica, 2020
Objective: The aim of this study was to compare the analgesic effects of intra-articular levobupivacaine alone, intra-articular levobupivacaine in combination with lornoxicam, and intra-articular levobupivacaine in combination with lornoxicam and ...
Onder Ersan   +3 more
doaj   +1 more source

Lornoxicam-induced hair loss

open access: yesJournal of Postgraduate Medicine, 2013
A patient started on 8 mg lornoxicam twice daily for pain in the hips developed acute-onset scalp hair loss. History and clinical examination revealed no evident abnormalities. Temporal association of the onset of hair loss with the use of lornoxicam, inability to explain hair loss by alternate causes, possibility of hair loss
M S, Keny, R R, Ghodge, S M, Bandekar
openaire   +2 more sources

Hell's Itch: A Self‐Case Report

open access: yesJEADV Clinical Practice, Volume 5, Issue 3, Page 982-985, September 2026.
ABSTRACT Hell's itch is a severely distressing dermatological condition characterized by the onset of incessant itching and intolerable pain 2–3 days post‐sunburn. It is underdiagnosed and underreported, and no definitive management framework has yet been developed.
Kai Peter Moors, Willem I. Visser
wiley   +1 more source

Comparing Early Postoperative Period Analgesic Effect of Dexketoprofene Trometamol and Lornoxicam in Mediastinoscopy Cases

open access: yesEurasian Journal of Medicine, 2019
Objective: In this study, we aimed comparing early postoperative period analgesic effectiveness and the effects on opioid consumption of intravenous dexketoprofen and lornoxicam that are given preemptively.
Gonul Sagiroglu
doaj   +1 more source

Functionalizing Conductive Diamond: Recent Advance in Fabrication, Modifications, and Applications

open access: yesCarbon Energy, Volume 8, Issue 5, May 2026.
This review highlights recent advancements in the synthesis, modification, and electrochemical applications of conductive diamond, particularly boron‐doped diamond (BDD). It emphasizes progress in fabrication methods, including CVD and HPHT, and explores modifications such as doping, surface terminations, and composite design, enabling significant ...
Ning Linghu, Xin Jiang, Jing Xu
wiley   +1 more source

Formulation and Evaluation of Ion-Responsive in Situ Gel for Ocular Delivery of Lornoxicam: In Vitro and In Vivo Studies

open access: yesIraqi Journal of Pharmaceutical Sciences
Lornoxicam (LOX) is a potent nonsteroidal anti-inflammatory drug (NSAID) oxicam class; that can be used into treat ocular inflammation; when applied locally to the eye, reducing systemic side effects.
Riyam Sadiq Jaffer, Hanan Jalal Kassab
doaj   +1 more source

Effects of Omega-3 Co-Administered with Therapeutic Dose of lornoxicam on Male Rats' Liver

open access: yesIraqi Journal of Pharmaceutical Sciences, 2019
The purpose of this study was to investigate the effect of omega-3 poly unsaturated fatty-acids co-administered with the therapeutic dose of lornoxicam on liver of healthy rats.
Israa A. Majeed, Nada N. Al-Shawi
doaj   +1 more source

Actionable Pharmacogenomics and Essential Medicines: An Analysis of WHO and African Lists for Safer and Efficacious Drug Use

open access: yesClinical Pharmacology &Therapeutics, Volume 119, Issue 5, Page 1371-1381, May 2026.
The World Health Organization Model Essential Medicines List and African national essential medicines lists (EMLs) detail drugs intended to be consistently available within national health systems, thereby supporting clinicians and pharmacists in making evidence‐based treatment decisions.
Tinashe A. Mazhindu   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy